About LUPRODEX DEPOT 22.5MG
Experience optimum hormone therapy with LUPRODEX DEPOT 22.5MG, now at a reduced price for a limited time-ending soon! Highlighted as a dominant solution for advanced prostate cancer, this splendid depot injection contains 22.5 mg of Leuprolide Acetate, formulated as a single-dose, white lyophilized powder. Designed for intramuscular administration every three months, it ensures patient convenience and compliance. Marketed by Sun Pharma, this allopathic medicine is supplied in a 1 x 1 vial packaging, requiring reconstitution and refrigerated storage. Regulatory approval is secured for your peace of mind.
Applied Use and Therapeutic Applications
LUPRODEX DEPOT 22.5MG is used as a primary hormone therapy for adults suffering from advanced prostate cancer. Its optimum depot formulation ensures sustained hormone suppression over three months, making it suitable for those requiring long-term management. Administered intramuscularly, this splendid solution is activated upon reconstitution and is strictly for use as directed by a physician. Its single-dose vial packaging simplifies the treatment process, optimizing patient care in oncological practices and hospital settings.
Export Markets, Handling, and Certification
LUPRODEX DEPOT 22.5MG is exported globally, with dominant market demand in regions such as Asia, Africa, and the Middle East. Strict sample policy protocols are followed before drop-off, ensuring product quality and regulatory compliance. Every handover and transportation step is carefully managed to maintain the cold chain at 2-8C. The product comes with all necessary certifications and regulatory approvals, reassuring importers and healthcare professionals about its authenticity and efficacy.
FAQ's of LUPRODEX DEPOT 22.5MG:
Q: How should LUPRODEX DEPOT 22.5MG be administered for best results?
A: LUPRODEX DEPOT 22.5MG is administered as an intramuscular injection after reconstitution. It is designed for use every three months or as directed by a healthcare provider for optimum hormone therapy in prostate cancer patients.
Q: What are the main benefits of choosing LUPRODEX DEPOT 22.5MG?
A: LUPRODEX DEPOT 22.5MG offers a dominant, long-acting solution for hormone suppression in advanced prostate cancer, reducing the frequency of injections to once every three months and supporting optimum therapeutic outcomes.
Q: When does one need to reconstitute LUPRODEX DEPOT 22.5MG, and how is it stored?
A: Reconstitution is required immediately before administration. The product should be stored at 2-8C until use to maintain its stability and efficacy.
Q: Where is LUPRODEX DEPOT 22.5MG typically supplied and exported?
A: LUPRODEX DEPOT 22.5MG is supplied across India and exported globally to Asia, Africa, the Middle East, and other regions utilizing certified transportation for secure drop-off and handover.
Q: What process ensures the quality and certification of LUPRODEX DEPOT 22.5MG during transit?
A: A strict process is followed during transportation, including cold chain management and certification checks, ensuring the medicine's quality and compliance from manufacturer to recipient.